Literature DB >> 26759583

Cylindroma of the scalp.

Majid Rostami Mogaddam1, Nasrollah Maleki2.   

Abstract

Entities:  

Year:  2015        PMID: 26759583      PMCID: PMC4696381          DOI: 10.4103/1735-1995.170638

Source DB:  PubMed          Journal:  J Res Med Sci        ISSN: 1735-1995            Impact factor:   1.852


× No keyword cloud information.
Sir, A 56-year-old woman presented with a long-standing history of slow-growing multiple scalp nodules. Her daughter and aunt also had a history of similar cutaneous lesions. Physical examination revealed multilobulated, large, epiphytic pink nodules, 2.5 cm by 6 cm in the greatest dimension, on the scalp [Figure 1]. The nodules were painless, solid, and movable from the underlying surface. Results of the routine laboratory examinations were normal. The histopathology of the scalp nodule revealed a well-defined dermal lesion composed of islands and cords of dark basaloid cells arranged in a jigsaw puzzle-like pattern and separated by hyaline basement membrane material, which was suggestive of cylindroma [Figure 2]. This patient underwent staged procedures, with debulking surgery followed by contouring with split-thickness skin graft. After 1 year, she was lost to follow-up.
Figure 1

Physical examination revealed multilobulated large epiphytic pink nodules, 2.5 cm by 6 cm in the greatest dimension, on the scalp

Figure 2

The histopathology of the scalp nodule revealed a well-defined dermal lesion composed of islands and cords of dark basaloid cells arranged in a jigsaw puzzle-like pattern

Physical examination revealed multilobulated large epiphytic pink nodules, 2.5 cm by 6 cm in the greatest dimension, on the scalp The histopathology of the scalp nodule revealed a well-defined dermal lesion composed of islands and cords of dark basaloid cells arranged in a jigsaw puzzle-like pattern Cylindromas are benign skin appendage tumors. They can be seen in conjunction with spiradenomas and trichoepitheliomas, and this condition is known as Brooke-Spiegler syndrome (BSS).[1] BSS is a rare autosomal dominant disorder caused by mutations of the cylindromatosis gene (CYLD) located at 16q12-q13.[2] The penetrance of the gene has been estimated to be between 60% and 100%.[3] Histologically, the tumors are circumscribed, nonencapsulated dermal nodules composed of islands and cords of basaloid cells surrounded by a thick, hyalinized, periodic acid-Schiff (PAS)-positive basement membrane. The cells are arranged in an interlocking “jigsaw-puzzle”-like architecture.[4] Treatment options in BSS are mainly for cosmetic concern. For solitary tumors, surgical excision is the treatment of choice. Other forms of therapy include electrodesiccation, curettage, cryosurgery, and excision with the use of carbon dioxide or neodymium-doped yttrium aluminum garnet; Nd:Y3Al5O12 (Nd:YAG) laser.[56] Topical 5% imiquimod cream has been advocated as a useful treatment.[7] Recently, it was suggested that targeting nuclear factor (NF)-κB in cylindroma therapy may be of therapeutic potential in patients with multiple tumors in the course of BSS. In one case of familial trichoepitheliomas, significant improvement was achieved with a combination of adalimumab and aspirin. This combination was chosen in order to block tumor necrosis factor alpha (TNFα)-induced activation of NF-κB at two different levels of the signaling pathway.[8] Several therapeutic agents including sodium salicylate, cyclooxygenase (COX)2 inhibitors (i.e., celecoxib), corticoids and prostaglandins as well as phytomedical products inhibit NF-κB activity and thus, may be of benefit in BSS.[9] However, their possible clinical efficacy remains to be elucidated.

AUTHOR'S CONTRIBUTION

MRM contributed in the conception of the work, conducting the study, and revising the draft. NM and NSA designed the study and were responsible for the overall study management. All authors approved the final version of the manuscript, and agreed with regard to all aspects of the work.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  9 in total

1.  Treatment of multiple familial trichoepitheliomas with a combination of aspirin and a neutralizing antibody to tumor necrosis factor alpha: A case report and hypothesis of mechanism.

Authors:  Galen H Fisher; Roy G Geronemus
Journal:  Arch Dermatol       Date:  2006-06

2.  Cylindroma as tumor of hair follicle origin.

Authors:  Ramin Massoumi; Maurizio Podda; Reinhard Fässler; Ralf Paus
Journal:  J Invest Dermatol       Date:  2006-05       Impact factor: 8.551

3.  Brooke-Spiegler syndrome: treatment with laser ablation.

Authors:  D Rallan; C C Harland
Journal:  Clin Exp Dermatol       Date:  2005-07       Impact factor: 3.470

4.  Case of the Brooke-Spiegler syndrome.

Authors:  Hoang Ly; Martin M Black; Alistair Robson
Journal:  Australas J Dermatol       Date:  2004-11       Impact factor: 2.875

Review 5.  Cylindromatosis and the CYLD gene: new lessons on the molecular principles of epithelial growth control.

Authors:  Ramin Massoumi; Ralf Paus
Journal:  Bioessays       Date:  2007-12       Impact factor: 4.345

6.  Brooke-Spiegler syndrome - report of four families: treatment with CO2 laser.

Authors:  Roberto Adrián Retamar; F Stengel; M E Saadi; M C Kien; P Della Giovana; H Cabrera; E N Chouela
Journal:  Int J Dermatol       Date:  2007-06       Impact factor: 2.736

Review 7.  NF-kappaB as a potential molecular target for cancer therapy.

Authors:  Chae Hyeong Lee; Yong-Tark Jeon; Su-Hyeong Kim; Yong-Sang Song
Journal:  Biofactors       Date:  2007       Impact factor: 6.113

8.  Brooke-Spiegler syndrome associated with cylindroma, trichoepithelioma and eccrine spiradenoma.

Authors:  Mingfei Chen; Hong Liu; Xi'an Fu; Yongxiang Yu; Gongqi Yu; Hongqing Tian; Guizhi Zhou; Xianmei Lu; Shengli Chen
Journal:  Int J Dermatol       Date:  2013-12       Impact factor: 2.736

9.  Trichoepithelioma.

Authors:  Hillary Johnson; Mirin Robles; Hideko Kamino; Ruth F Walters; Arnold Lee; Miguel Sanchez
Journal:  Dermatol Online J       Date:  2008-10-15
  9 in total
  1 in total

Review 1.  Current Diagnosis and Treatment Options for Cutaneous Adnexal Neoplasms with Apocrine and Eccrine Differentiation.

Authors:  Iga Płachta; Marcin Kleibert; Anna M Czarnecka; Mateusz Spałek; Anna Szumera-Ciećkiewicz; Piotr Rutkowski
Journal:  Int J Mol Sci       Date:  2021-05-11       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.